Journal article

EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas

Dariush Etemadmoghadam, Walid J Azar, Ying Lei, Tania Moujaber, Dale W Garsed, Catherine J Kennedy, Sian Fereday, Chris Mitchell, Yoke-Eng Chiew, Joy Hendley, Raghwa Sharma, Paul R Harnett, Jason Li, Elizabeth L Christie, Ann-Marie Patch, Joshy George, George Au-Yeung, Gisela Mir Arnau, Timothy P Holloway, Timothy Semple Show all

Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2017

Grants

Awarded by Cancer Council New South Wales


Awarded by National Health and Medical Research Council of Australia


Awarded by Worldwide Cancer Research


Awarded by Cancer Australia


Awarded by U.S. Army Medical Research and Materiel Command


Awarded by National Health and Medical Research Council of Australia (NHMRC)


Awarded by NHMRC


Awarded by Cancer Institute New South Wales


Funding Acknowledgements

This work was supported by Cancer Council New South Wales (RG-15-23), The National Health and Medical Research Council of Australia (NHMRCID631701), Worldwide Cancer Research (09-0676), and Cancer Australia (1004673). The Australian Ovarian Cancer Study was supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania, and the National Health and Medical Research Council of Australia (NHMRC; ID400413, ID400281). The AOCS gratefully acknowledges additional support from S. Boldeman, the Agar family, Ovarian Cancer Australia and Ovarian Cancer Action (UK). The Gynaecological Oncology at Westmead, a member of the Australasian Biospecimen Network-Oncology group, was supported by grants from the NHMRC (ID310670 and ID628903) and the Cancer Institute New South Wales (12/RIG/1-17 and 15/RIG/1-16). A. de Fazio is supported by the University of Sydney Cancer Research Fund and Cancer Institute NSW, through the Sydney West Translational Cancer Research Centre. T. Moujaber is a recipient of a Westmead Medical Research Foundation PhD Scholarship.